Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor

Haematologica

Volumn 81, Issue 2, 1996, Pages 178-181

  La Nasa, Giorgio ^a   Pizzati, Antonella ^a   Ledda, Antonio ^a   Vacca, Adriana ^a   Arras, Marcella ^a   Contu, Licinio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Extended HLA haplotypes; Unrelated BMT; Wiskott Aldrich syndrome

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; FOLLOW UP; HAPLOTYPE; HLA TYPING; HUMAN; MALE; ORGAN DONOR; PRESCHOOL CHILD; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME;

ADULT; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; FEMALE; HAPLOTYPES; HLA ANTIGENS; HUMANS; MALE; TISSUE DONORS; WISKOTT-ALDRICH SYNDROME;

EID: 0030326144     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cooper MD, Chase HP, Lowman JT, Krivit W, Good R. Wiskott Aldrich syndrome: an immunologic deficiency disease involving the afferent limb of immunity. Am J Med 1968; 44:499-513.
2. Mullen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskon-Aldrich syndrome: long-term follow-up of 62 cases. Blood 1993; 82:2961-6.
3. Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiency: A report from the European group for BMT and the European group for immunodeficiency. Blood 1994; 83: 1149-54.
4. Rumelhart SL, Trigg ME, Horowitz SD, Hong R. Monoclonal antibody T-cell depleted HLA-haploidentical bone marrow-transplantation for Wiskott-Aldrich syndrome. Blood 1990; 75:1031-5.
5. Brochstein JA, Gillio AP, Ruggiero M, et al. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. J Pediatr 1991; 119:907-12.
6. Fischer A, Friedrich W, Fasth A, et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis and Fanconi's anemia: European group for immunodeficiency/European group for bone marrow transplantation Report. Blood 1991; 77: 249-56.
7. Filipovich AH, Shapiro RS, Ramsay NKC, et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992; 80:270-6.
8. Lenarsky C, Weimberg K, Kohn DB, Parkman R. Unrelated donor BMT for Wiskott-Aldrich syndrome. Bone Marrow Transplant 1993; 12:145-7.
9. Ash RC, Casper JT, Chitambar CR, et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990; 322: 485-94.
10. Awdeh ZL, Alper AC, Fici D, Eynon E, Bishara A, Yunis EJ. Predictability of alloreactivity among unrelated individuals. Tissue Antigens 1992; 39:51-7.
11. Contu L, La Nasa G, Arras M, et al. Successful unrelated bone marrow transplantation in beta-thalassemia. Bone Marrow Transplant 1994; 13:329-31.
12. Morishima Y, Kodera Y, Hirabayashi N, et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15:235-9.